Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 76 M79 M80 M78 M70 M79 M 307 M Research & development —————— — Operating income 728 M748 M804 M761 M782 M802 M 3.15 B Non-Operating Income, Total 0001 M-1 M— — Interest expense, net of interest capitalized 383 M403 M403 M375 M337 M354 M 1.47 B Non-Operating Income, excl. Interest Expenses -383 M-403 M-403 M-374 M-338 M— — Unusual income/expense —————— — Pretax income 285 M309 M344 M342 M342 M340 M 1.37 B Equity in earnings —————— — Taxes 63 M64 M78 M77 M76 M66 M 297 M Non-controlling/minority interest 4 M4 M4 M4 M4 M4 M 16 M After tax other income/expense —————— — Net income before discontinued operations 218 M241 M262 M261 M262 M270 M 1.05 B Discontinued operations —————— — Net income 218 M241 M262 M261 M262 M270 M 1.05 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 213 M233 M254 M256 M257 M260 M 1.03 B Basic earnings per share (Basic EPS) 0.410.460.50.520.540.55 2.11 Diluted earnings per share (Diluted EPS) 0.410.450.50.510.530.54 2.08 Average basic shares outstanding 517.12 M508.13 M504.86 M505.13 M480.31 M474.84 M — Diluted shares outstanding 523.42 M513.61 M510.35 M511.11 M486.87 M480.1 M — EBITDA 733 M744 M782 M758 M789 M802 M 3.13 B EBIT 712 M724 M776 M741 M767 M782 M 3.07 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 21 M20 M6 M17 M22 M20 M 65 M